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STUDY QUESTION: Are infertile women who screen positive for depression less likely to initiate infertility treatments?
SUMMARY ANSWER: Infertile women who screen positive for depression are less likely to initiate treatment for infertility.
WHAT IS ALREADY KNOWN: Infertility imposes a psychological burden on many couples. Depression and anxiety have been demon-
strated in ~40% of infertile women, which is twice that of fertile women. Further, the psychological burden associated with infertility treat-
ment has been cited as a major factor for discontinuation of infertility care.
STUDY DESIGN, SIZE, DURATION: Prospective, observational study in a clinical-based cohort of 416 women who completed a ques-
tionnaire after the new patient visit, from January 2013 until December 2014 inclusive.
PARTICIPANTS/MATERIALS, SETTING, METHODS: All new female infertility patients (n = 959) seen between January 2013 and
December 2014 at University of North Carolina Fertility received an electronic questionnaire to screen for mental health disorders and to
evaluate their perception of mental health disorders on infertility.
MAIN RESULTS AND THE ROLE OF CHANCE: Of 959 surveys sent, 416 women completed the questionnaire (43%). The prevalence
screening positive for depression, using the NIH PROMIS screening tool, was 41%. Sixty-two percent of all women initiated infertility treat-
ment, and of these, 81% did so within 4 months. In multivariate analysis, women who screened positive for depression had 0.55 times the
odds of initiating treatment for infertility (95% CI: 0.31–0.95). Similarly, women who screened positive for depression had 0.58 times the
odds of initiating infertility treatment within 4 months (95% CI: 0.35–0.97), which was the time of censoring from the most recent patient
evaluated. Women who screened positive for depression were less likely to pursue treatment with oral medications or IVF (P = 0.01 and
P = 0.03, respectively), as compared to women who did not screen positive for depression.
LIMITATIONS, REASONS FOR CAUTION: Questionnaire-based evaluations may result in a lower prevalence of psychological dis-
order as some participants feign emotional well-being. Although we did not identify differences in women who responded to our survey and
those who did not, responder bias may still be present. In addition, infertility is a couple’s disease. However, this study only included psycho-
logical evaluation of the female partner. We have no information about the women’s previous treatment.
WIDER IMPLICATIONS OF THE FINDINGS: Screening for depression is important in the infertility patient population, as further evalu-
ation and psychological interventions may improve compliance with fertility treatments, quality of life, and potentially, the overall chance of
pregnancy.
STUDY FUNDING/COMPETING INTERESTS: None.
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Introduction
Infertility imposes a psychological burden on many couples. Most infer-
tile couples believe that infertility induces considerable life stress
(Mahlstedt et al., 1987; Cousineau and Domar, 2007). In addition,
patients with infertility are more likely to suffer from a psychiatric ill-
ness than fertile patients (Noorbala et al., 2009; Domar, 2015).
Specifically, depression has been demonstrated in ~40% of infertile
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women, which is twice that of fertile women (Domar et al., 1992;
Chen et al., 2004).
Although previous studies have evaluated the association between
psychological disorders and infertility, the outcome of interest in these
studies is traditionally pregnancy. Attempts to reduce the psycho-
logical stress associated with infertility have been associated with high-
er quality of life and higher pregnancy rates, but not a decrease in the
rate of patient drop out (Domar et al., 2015; Frederiksen et al., 2015).
Further, the psychological burden associated with infertility treatment
has been cited as a major factor for discontinuation of infertility care
(Domar, 2004; Gameiro et al., 2012). Previous studies evaluating the
association between depression and initiation of fertility treatments
have yielded mixed results (Malcolm and Cumming, 2004; Brandes
et al., 2009; Eisenberg et al., 2010; Lopes et al., 2014). In the only
evaluation in US couples, 20% of couples who did not pursue treat-
ment after an initial evaluation for infertility cited ‘emotional stress’ as
the primary reason and scored higher on a screen for depression than
women who pursued treatment (Eisenberg et al., 2010).
The objective of this study is to determine if screening positive for
depression, with a brief, validated questionnaire, is correlated with
pursuing treatment for infertility. No studies have prospectively evalu-
ated time to infertility treatment initiation or differences in type of
infertility treatment in women who screen positive for depression as
compared to those who do not. We hypothesize that women who
screen positive for depression at after the initial consultation will be
less likely to initiate infertility treatment. Thus, the identification of
women who would benefit from further evaluation and psychological
interventions may improve compliance with fertility treatments and
potentially, the ultimate outcome of pregnancy.
Materials andMethods
All new infertility patients seen between 1 January 2013 and 31 December
2014 at University of North Carolina Fertility received an electronic ques-
tionnaire to screen for mental health disorders and to evaluate their per-
ception of mental health disorders on infertility. Women age 18–41 years
who were seeking infertility treatment and had the ability to read and
speak English were included in the study. Email addresses were provided
by patients who consented to email correspondence. The electronic ques-
tionnaire was sent after the new patient visit at our institution (although
patients may be in various stages of infertility care and treatment if they
had previously seen another provider). Data regarding patients’ demo-
graphic and medical information were extracted from the medical record.
Estimated annual income was calculated using an income tax database by
home zip code (Melissa Data, 2016).
The questionnaire was developed using a validated tool for depression
and by reproductive specialists familiar with mental health disorders and
infertility. Questions were generated with the objective of evaluating
patient perception of mental health disorders and infertility and to screen
for depression. The questionnaire included 12 questions (multiple choice
or Likert scale responses) assessing patient perception of the impact men-
tal health disorders have on infertility and identification of barriers for men-
tal health care. Screening for depression was performed using the National
Institutes of Health Patient Reported Outcomes Measurement
Information System (PROMIS) 4-item short form (Pilkonis et al., 2011).
This validated measure includes four questions, each with a Likert scale,
and standardized method for scoring (see Supplementary Table SI).
Possible scores are integers, between 4 and 20. Depression was dichoto-
mized, per scoring protocols, as present when a subject scored more than
8 on the NIH PROMIS depression short form. The survey also included
further questions regarding some demographic information (race, marital
status, education level) and pregnancy and fertility history. The questions
were reviewed by physicians for content and by non-physicians for clarity.
Subjects were prospectively evaluated via chart review to determine the
timing of initiating treatment for infertility. Time to treatment was defined
as months from initial new patient consultation to initiation any of the fol-
lowing infertility treatments: fertility medications, intrauterine insemination,
IVF or fertility surgery. Only women who had treatment recommended by
their physician were included in the analysis (for example, if expectant
management was recommended, women were excluded). In order, to
take into account patients who were most recently seen, treatment was
dichotomized for analysis as both (i) initiation of any infertility treatment
and (ii) initiation of any treatment within 4 months (as censoring occurred
at 4 months from the most recently seen patient).
Statistical analysis
Descriptive statistics were generated for all variables, and bivariate ana-
lyses were conducted using Student’s t-test and Pearson’s Χ2 for continu-
ous and categorical variables, respectively. Bivariate analyses were
conducted to evaluate the differences between women who screened
positive for depression and those who did not and the differences between
those who pursued infertility treatment and those who did not. A logistic
regression model evaluated the odds of initiating infertility treatment by
status of depression screening. The full model included all variables that
were associated with the exposure, a risk factor for the outcome and not
on the causal pathway. A change in the effect method was used to remove
variables that were not confounders. The final model included the follow-
ing covariates: age, education level, BMI and duration of infertility. For
modeling, age and BMI were continuous variables; education was categor-
ized into three categories: less than a college degree, college degree and at
least some graduate work; and duration of infertility was categorized into
three categories: <1 year, 1–2 years and >2 years. All analyses were car-
ried out with the use of STATA statistical software (version 13.0;
StataCorp LP, College Station, TX, USA).
Ethical approval
This study was approved by the Institutional Review Board at the
University of North Carolina at Chapel Hill.
Results
Of 959 surveys sent, 416 women completed the questionnaire, yield-
ing a response rate of 43%. There were no significant demographic dif-
ferences, as obtained by the medical record, between women who did
and did not respond. Overall, 50% of women in this study were <35
years. Most participants were Caucasian (80%) and highly educated
(86% with at least a college degree). The majority of the women were
overweight (BMI > 25) or obese (BMI > 30) (58%) and had been
attempting conception for more than 2 years (57%). The most com-
mon infertility diagnoses were unexplained (33%), anovulation (21%),
male (17%) and diminished ovarian reserve (14%) (Table I).
Fifty percent of women with infertility reported feeling depressed
most or all of the time. The prevalence of screening positive for
depression in our cohort, as determined by a positive PROMIS depres-
sion screen, was 41%. Women who screened positive for depression
were more likely to be nulliparous, of a higher BMI, and with a duration
of infertility more than 2 years, as compared to women without
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depression (Table I). No difference in infertility diagnosis was detected
between women who did and did not screen positive for depression.
After the initial new infertility consultation, 62% of women initiated
infertility treatment. Of those that did initiate treatment, the mean time
to treatment was 3 months. Eighty-one percent of women who initiated
treatment did so within 4 months of initial evaluation. Women who
initiated treatment were more likely to be <35 years of age, Caucasian,
married, parous and with a normal BMI as compared to women who
did not ever initiate treatment (Table II). In addition, diagnosis signifi-
cantly differed between women who pursued treatment and those who
did not (P = 0.04), with women who pursued treatment more com-
monly having a diagnosis of anovulation and male factor infertility.
Thirty-six percent of women who screened positive for depression
initiated infertility treatments, as compared to 64% of women without
depression (P = 0.02). Of women who did initiate fertility treatments,
women who screened positive for depression were significantly less likely
to pursue treatment with oral medications or IVF as compared to
women who screened negative (Table III). In multivariate analysis, after
adjusting for age, education level, BMI and duration of infertility, women
who screened positive for depression had 0.55 times the odds of
.............................................................................................................................................................................................
Table I Patient characteristics overall and stratified by screening for depression.
Overall (n = 416) Negative depression
screen (n = 174)
Positive depression
screen (n = 122)
P value
Age (years)
<35 50 50 53
0.28
35–37 19 21 18
38–40 15 17 12
>40 16 12 17
Age (years) 35.1 (5.3) 34.9 (6.1) 34.6 (5.4) 0.54
Race
Caucasian 80 82 78
0.40Other 20 18 22
Married 92 94 89 0.12
Education
Less than college degree 14 10 19
0.93
College degree 39 39 41
At least some graduate work 47 51 40
Income
< $40 000 per year 9 6 14
<0.01
$40 000–80 000 per year 30 25 38
> $80 000 per year 61 69 48
BMI (kg/m2) 27.5 (7.4) 26.7 (8.2) 29.1 (7.4) <0.01
BMI (kg/m2)
<18.5 1 2 1
0.25
18.5–24.9 41 44 34
25–29.9 22 23 25
>30 36 32 41
Parous 54 71 30 <0.01
Prior pregnancy loss 41 38 45 0.26
Infertility diagnosis
Unexplained 33 38 30
0.30
Anovulation 21 22 22
Male 17 17 16
Diminished ovarian reserve 14 14 13
Other 15 9 19
Duration of infertility
<1 year 10 12 5
0.02
1–2 years 33 37 29
>2 years 57 51 66
Data are mean (SD) or %.
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initiating treatment for infertility (95% CI: 0.31–0.95) (Table IV). Similarly,
women who screened positive for depression had 0.58 times the odds
of initiating infertility treatment within 4 months (95% CI: 0.35–0.97).
Discussion
Overall, screening positive for depression was common (41%) in our
cohort. Women who screened positive for depression were more
likely to be overweight or obese, nulliparous and with a longer dur-
ation of infertility than women who screened negative. Most women in
our cohort initiated treatment for infertility. However, women with a
positive depression screen were significantly less likely to initiate treat-
ment for infertility than women who screened negative, even after
adjusting for age, education level, BMI and duration of infertility.
The prevalence of a positive depression screen in our cohort
(women seeking initial infertility evaluation) was 41% as determined by
validated questionnaire. Similarly, a study evaluating a similar study
population to ours (Caucasian and well-educated), at initial infertility
evaluation (n = 448) reported a prevalence of major depressive dis-
order of 39.1% as determined by structured interview (Holley et al.,
2015). A similar prevalence (28%) was found in infertile patients
undergoing IVF (Pasch et al., 2012). The rate of a positive depression
screen in our cohort is consistent with that reported studies, likely giv-
ing support for the validity of the NIH PROMIS tool in this population.
In our study, women who screened positive for depression were
more likely to be overweight or obese, nulliparous and trying to con-
ceive for over 2 years. In contrast, Holley et al. (2015) did not find a
........................................................................................
Table II Unadjusted associations between each patient
characteristic and initiation of fertility treatment.
No fertility
treatments
(n= 155)
Initiated fertility
treatments
(n = 257)
P value
Age (years)
<35 39 57
<0.01
35–37 18 20
38–40 19 13
>40 26 10
Age (years) 36.5 (6.1) 34.5 (5.4) <0.01
Race
Caucasian 68 85
<0.01Other 32 15
Married 84 96 <0.01
Education
Less than college
degree
21 11
0.08
College degree 37 41
At least some
graduate work
42 48
Income
< $40 000 per
year
15 7
0.11
$40 000–80 000
per year
28 30
> $80 000 per
year
57 63
BMI (kg/m2) 28.3 (7.1) 27.0 (7.2) 0.08
BMI (kg/m2)
<18.5 1 2
0.01
18.5–24.9 35 45
25–29.9 19 24
>30 45 29
Parous 40 61 <0.01
Prior pregnancy loss 44 40 0.48
Infertility diagnosis
Unexplained 30 34
0.04
Anovulation 10 21
Male 14 18
Diminished
ovarian reserve
22 14
Other 24 13
Duration of infertility
<1 year 9 10
0.22
1–2 years 27 37
>2 years 64 53
Data are mean (SD) or %.
........................................................................................
Table III Fertility treatment type, stratified by
screening for depression.
Negative
depression
screen (n= 174)
Positive
depression
screen (n = 122)
P value
Oral
medications
62 47 0.01
Injectable
medications
30 23 0.19
Intrauterine
insemination
33 25 0.17
IVF 29 19 0.03
Data are in %.
........................................................................................
Table IV Unadjusted and adjusted odds ratiosa for
patients initiating treatment for infertility who screen
positive relative to those who screen negative for
depression.
Odds ratio (95% CI)
Initiating treatment
Unadjusted 0.54 (0.32–0.90)
Adjustedb 0.55 (0.31–0.95)
Initiating treatment within 4 months
Unadjusted 0.57 (0.36–0.92)
Adjustedb 0.58 (0.35–0.97)
aBased on a logistic regression model.
bAdjusted for age, duration of infertility, BMI and education level.
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significant association with depression and either duration of infertility
or number of failed treatment cycles. A study by Volgsten et al. (2010)
reported that infertile women with a anxiety or depression were more
likely to be overweight (BMI > 30 kg/m2) than infertile women with-
out psychiatric diagnosis. Given our findings that patients with obesity,
nulliparity and a long duration of infertility may be more likely to have
depression, careful consideration should be given to carefully screen
such women for the presence of depression.
Our study revealed an association between a positive depression
screen and failure to initiate infertility treatment. Previous studies evalu-
ating the association between psychological distress and initiating treat-
ment for infertility have been mixed. Malcolm and Cumming (2004)
evaluated Canadian women who did not pursue infertility treatment
(n = 329) via telephone interview, and ‘emotional distress’ was cited as
the reason for discontinuation in only 1.2% of couples . Further, Lopes
et al. (2014) found that Portuguese women (n = 291) with psycho-
logical maladjustment (as determined using the Fertility Quality of Life
scale) still reported high intentions to proceed with infertility treatment.
In contrast, in a large cohort of women undergoing infertility treatment
in the Netherlands (n = 1391), Brandes et al. (2009) found that 45% of
women dropped out before starting any form of infertility treatment
after initial evaluation, with 11% citing emotional distress as the principal
reason after telephone follow-up. Eisenberg et al. (2010) evaluated 434
couples after initial infertility evaluation and found that 13% did not
undergo any treatment for infertility. Twenty percent of those not purs-
ing treatment cited ‘emotional stress’ as the reason, and a higher score
on the depression screen (20-item Center for Epidemiologic Studies
Depression Scale, CES-D) was correlated with not pursuing treatment.
Our findings are similar as women who screen positive for depression,
as determined by a validated tool, are less likely to initiate treatment for
infertility in a US population. We also specifically identified that these
women are significantly less likely to pursue treatment options with oral
medications or IVF as compared to women who screened negative.
While emotional distress is frequently cited as a reason for discon-
tinuation of infertility treatment, financial burden is also an important
factor in many cases. The impact depression and emotional stress
have on treatment decisions may best be evaluated in areas with subsi-
dized coverage for IVF to exclude financial restrictions. In the previ-
ously discussed study by Brandes et al. (2009), 34% of women
discontinued further infertility treatment due to emotional distress. In
974 couples from Sweden, 54% of women discontinued treatments
before completion of the three covered IVF cycles, most commonly
due to psychological burden (26%) (Olivius et al., 2004). Further,
Domar et al. (2010) evaluated US women with insurance coverage for
three IVF cycles (n = 47), with a drop-out rate of 34% before the last
cycle. The most cited reason for discontinuation of care was emo-
tional, with 39% of women reporting psychological burden and need-
ing a break. In contrast, Van Dongen et al. (2015) recently evaluated
Dutch couples undergoing IVF (n = 667) and found no association
between depression (as determined by the validated SCREENIVF tool)
and discontinuation of treatment, although lack of social support was
associated with treatment drop-out. However, it appears that even
when the financial burden of costly infertility treatment is removed,
couples with a higher level of psychological stress or depression are
less likely to continue with additional treatment for infertility.
Strengths of this study include the use of validated measures of psy-
chological assessment and the prospective nature of our evaluation.
Although not previously used in an infertile population, the PROMIS
depression form has been validated for use in screening for depres-
sion in diverse patient populations (Choi et al., 2014; Stone et al.,
2015; Schalet et al., 2016). Prior studies have correlated the PROMIS
short forms for depression with other standard measures of depres-
sion screening, including the Zung depression scale, the CES-D and
the 9-item Patient Health Questionnaire (Hung et al., 2015; Kim
et al., 2015). In addition, our electronic questionnaire had a good
response rate without demographic differences noted between
women who did and did not respond. Our study is also the first to
investigate the difference in treatment type pursued based on screen-
ing positive for depression.
Our study is not without limitations. Questionnaire-based evalua-
tions may result in a lower prevalence of psychological disorder as
some participants feign emotional well-being (Cousineau and Domar,
2007). Therefore, the true prevalence of depression in our study
population may be higher than stated. In addition, infertility is a cou-
ple’s disease. However, this study only included psychological evalu-
ation of the female partner. Further, the financial strain of infertility
treatment may dictate the ability to pursue treatment. However, it is
difficult to account for an individual’s financial status, as it may not be
intrinsically tied to reported income and patients often decline to
answer questions about income. We opted to include education in
our model, as educational level and financial status are frequently cor-
related and a significant difference was seen between the educational
levels in women with and without depression in out cohort. In add-
ition, many women present to a fertility clinic at different time periods
in their fertility journey. Although we evaluated patients for depression
after the new patient visit, it is important to note that women may
have pursued infertility evaluation or treatment before presenting to
us for care. Thus, we are truly evaluating the association between
screening positive for depression and the initiation of fertility treat-
ments at a new clinic. In addition, no correction was made for multiple
comparisons.
In summary, our study reveals that infertile women who screen posi-
tive for depression are less likely to initiate treatment for infertility. As
the relationship between infertility and depression is complex, better
understanding of the lasting impact of depression on infertility is cru-
cial. As women with a positive depression screen are less likely to initi-
ate infertility treatment, the importance of provider evaluation at initial
visit should be stressed. Although screening positive for depression is
not equivalent to a clinical diagnosis of depression, appropriate screen-
ing for depression will help to identify women who may benefit from
further evaluation and psychological interventions which may improve
compliance with fertility treatments, thus helping to achieve the ultim-
ate goal of pregnancy.
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Supplementary data are available at Human Reproduction online.
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